Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera

被引:5
作者
Davidovitz, Y
Lev, D
Ballin, A
Tsudik, A
Meytes, D
机构
[1] E Wolfson Med Ctr, Dept Hematol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Dept Genet, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1016/S0165-4608(97)00255-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a novel chromosomal translocation (1;20)(q32;q13.3) in a patient with myelofibrosis following polycythemia vera. This 73-year-old woman developed myelofibrosis 6 years after the initial diagnosis of polycythemia vera (PV). The course of PV was uneventful. Subsequent to the diagnosis, the patient was treated with phlebotomy and low doses of hydroxyurea for 4 years. No therapy was been use of evolving anemia demonstrated myelofibrosis and a chromosomal aberration-t(1;20)(q32;q13.3). Aberrations in chromosomes 4 and 20 have been reported in myeloproliferative disorders, but a t(1;20) translocation has not been reported. Because a karyotype analysis was not performed at the time PV was diagnosed, whether this translocation is linked to the primary disease (PV) or to the transition to myelofibrosis is not known. (C) Elsevier Science Inc., 1998.
引用
收藏
页码:156 / 158
页数:3
相关论文
共 10 条
[1]   CLINICAL-SIGNIFICANCE OF THE DEL(20Q) CHROMOSOME IN HEMATOLOGIC DISORDERS [J].
AATOLA, M ;
ARMSTRONG, E ;
TEERENHOVI, L ;
BORGSTROM, GH .
CANCER GENETICS AND CYTOGENETICS, 1992, 62 (01) :75-80
[2]   TRANSITIONS AMONG MYELOPROLIFERATIVE DISORDERS [J].
GLASSER, RM ;
WALKER, RI .
ANNALS OF INTERNAL MEDICINE, 1969, 71 (02) :285-+
[3]  
HILL DW, 1976, SEMIN HEMATOL, V13, P13
[4]   CYTOGENETIC ABNORMALITIES AND LEUKEMIC TRANSFORMATION IN HYDROXYUREA-TREATED PATIENTS WITH PHILADELPHIA-CHROMOSOME NEGATIVE CHRONIC MYELOPROLIFERATIVE DISEASE [J].
LOFVENBERG, E ;
NORDENSON, I ;
WAHLIN, A .
CANCER GENETICS AND CYTOGENETICS, 1990, 49 (01) :57-67
[5]  
MARTIN JLD, 1991, MAYO CLIN P, V66, P287
[6]  
MILLER JB, 1985, CANCER, V55, P582, DOI 10.1002/1097-0142(19850201)55:3<582::AID-CNCR2820550318>3.0.CO
[7]  
2-O
[8]   TRISOMY 1Q IN POLYCYTHEMIA-VERA AND ITS RELATION TO DISEASE TRANSITION [J].
SWOLIN, B ;
WEINFELD, A ;
WESTIN, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1986, 22 (02) :155-167
[9]   KARYOTYPIC PATTERNS AND THEIR CLINICAL-SIGNIFICANCE IN POLYCYTHEMIA-VERA [J].
TESTA, JR ;
KANOFSKY, JR ;
ROWLEY, JD ;
BARON, JM ;
VARDIMAN, JW .
AMERICAN JOURNAL OF HEMATOLOGY, 1981, 11 (01) :29-45
[10]  
TESTA JR, 1980, CANC GENET CYTOGENET, V1, P307